EU-European Union drug regulators have begun reviewing a new Russian-made coronavirus vaccine.
Meanwhile, regulatory officials have pointed out that safety data are still inadequate, and it will take some time before the decision to issue a vaccine permit is made.
The EU drug authority EMA = European Medicines Agency began reviewing the Russian-developed new coronavirus vaccine "Sputnik V" last week and is considering whether to issue a permit to use the vaccine.
However, an EMA executive appeared on an Austrian public broadcaster on the 7th, pointing out that safety data is still inadequate, and said that Sputnik V was "like Russian roulette." I did.
A spokesman for the Russian Presidential Administration, Peskov, criticized the statement on the 9th as "inappropriate."
On the other hand, Russian government funds that supply vaccines overseas say that they are making adjustments toward the production of vaccines in Italy.
It will take several months for the EMA to decide whether to license the Russian vaccine, but Russia is expected to step up its efforts to reach out to each country without waiting for the EMA's review results.